Copyright Reports & Markets. All rights reserved.

Global CRISPR Genome Editing Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 CRISPR Genome Editing Market Overview

    • 1.1 Product Overview and Scope of CRISPR Genome Editing
    • 1.2 Classification of CRISPR Genome Editing by Types
      • 1.2.1 Global CRISPR Genome Editing Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global CRISPR Genome Editing Revenue Market Share by Types in 2018
      • 1.2.3 Genetic Engineering
      • 1.2.4 Gene Library
      • 1.2.5 Human Stem Cells
      • 1.2.6 Others
    • 1.3 Global CRISPR Genome Editing Market by Application
      • 1.3.1 Global CRISPR Genome Editing Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Biotechnology Companies
      • 1.3.3 Pharmaceutical Companies
      • 1.3.4 Others
    • 1.4 Global CRISPR Genome Editing Market by Regions
      • 1.4.1 Global CRISPR Genome Editing Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) CRISPR Genome Editing Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) CRISPR Genome Editing Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) CRISPR Genome Editing Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) CRISPR Genome Editing Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) CRISPR Genome Editing Status and Prospect (2014-2024)
    • 1.5 Global Market Size of CRISPR Genome Editing (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Editas Medicine
      • 2.1.1 Business Overview
      • 2.1.2 CRISPR Genome Editing Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Editas Medicine CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 CRISPR Therapeutics
      • 2.2.1 Business Overview
      • 2.2.2 CRISPR Genome Editing Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 CRISPR Therapeutics CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Horizon Discovery
      • 2.3.1 Business Overview
      • 2.3.2 CRISPR Genome Editing Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Horizon Discovery CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Sigma-Aldrich
      • 2.4.1 Business Overview
      • 2.4.2 CRISPR Genome Editing Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Sigma-Aldrich CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Genscript
      • 2.5.1 Business Overview
      • 2.5.2 CRISPR Genome Editing Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Genscript CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Sangamo Biosciences
      • 2.6.1 Business Overview
      • 2.6.2 CRISPR Genome Editing Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Sangamo Biosciences CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Lonza Group
      • 2.7.1 Business Overview
      • 2.7.2 CRISPR Genome Editing Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Lonza Group CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Integrated DNA Technologies
      • 2.8.1 Business Overview
      • 2.8.2 CRISPR Genome Editing Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Integrated DNA Technologies CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 New England Biolabs
      • 2.9.1 Business Overview
      • 2.9.2 CRISPR Genome Editing Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 New England Biolabs CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Origene Technologies
      • 2.10.1 Business Overview
      • 2.10.2 CRISPR Genome Editing Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Origene Technologies CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Transposagen Biopharmaceuticals
      • 2.11.1 Business Overview
      • 2.11.2 CRISPR Genome Editing Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Transposagen Biopharmaceuticals CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Thermo Fisher Scientific
      • 2.12.1 Business Overview
      • 2.12.2 CRISPR Genome Editing Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Thermo Fisher Scientific CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 Caribou Biosciences
      • 2.13.1 Business Overview
      • 2.13.2 CRISPR Genome Editing Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 Caribou Biosciences CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 Precision Biosciences
      • 2.14.1 Business Overview
      • 2.14.2 CRISPR Genome Editing Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 Precision Biosciences CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Cellectis
      • 2.15.1 Business Overview
      • 2.15.2 CRISPR Genome Editing Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Cellectis CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 Intellia Therapeutics
      • 2.16.1 Business Overview
      • 2.16.2 CRISPR Genome Editing Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 Intellia Therapeutics CRISPR Genome Editing Revenue, Gross Margin and Market Share (2017-2018)

    3 Global CRISPR Genome Editing Market Competition, by Players

    • 3.1 Global CRISPR Genome Editing Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 CRISPR Genome Editing Players Market Share
      • 3.2.2 Top 10 CRISPR Genome Editing Players Market Share
    • 3.3 Market Competition Trend

    4 Global CRISPR Genome Editing Market Size by Regions

    • 4.1 Global CRISPR Genome Editing Revenue and Market Share by Regions
    • 4.2 North America CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 4.3 Europe CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 4.5 South America CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa CRISPR Genome Editing Revenue and Growth Rate (2014-2019)

    5 North America CRISPR Genome Editing Revenue by Countries

    • 5.1 North America CRISPR Genome Editing Revenue by Countries (2014-2019)
    • 5.2 USA CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 5.3 Canada CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico CRISPR Genome Editing Revenue and Growth Rate (2014-2019)

    6 Europe CRISPR Genome Editing Revenue by Countries

    • 6.1 Europe CRISPR Genome Editing Revenue by Countries (2014-2019)
    • 6.2 Germany CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 6.3 UK CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 6.4 France CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 6.5 Russia CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 6.6 Italy CRISPR Genome Editing Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific CRISPR Genome Editing Revenue by Countries

    • 7.1 Asia-Pacific CRISPR Genome Editing Revenue by Countries (2014-2019)
    • 7.2 China CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 7.3 Japan CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 7.4 Korea CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 7.5 India CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia CRISPR Genome Editing Revenue and Growth Rate (2014-2019)

    8 South America CRISPR Genome Editing Revenue by Countries

    • 8.1 South America CRISPR Genome Editing Revenue by Countries (2014-2019)
    • 8.2 Brazil CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia CRISPR Genome Editing Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue CRISPR Genome Editing by Countries

    • 9.1 Middle East and Africa CRISPR Genome Editing Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 9.3 UAE CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria CRISPR Genome Editing Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa CRISPR Genome Editing Revenue and Growth Rate (2014-2019)

    10 Global CRISPR Genome Editing Market Segment by Type

    • 10.1 Global CRISPR Genome Editing Revenue and Market Share by Type (2014-2019)
    • 10.2 Global CRISPR Genome Editing Market Forecast by Type (2019-2024)
    • 10.3 Genetic Engineering Revenue Growth Rate (2014-2024)
    • 10.4 Gene Library Revenue Growth Rate (2014-2024)
    • 10.5 Human Stem Cells Revenue Growth Rate (2014-2024)
    • 10.6 Others Revenue Growth Rate (2014-2024)

    11 Global CRISPR Genome Editing Market Segment by Application

    • 11.1 Global CRISPR Genome Editing Revenue Market Share by Application (2014-2019)
    • 11.2 CRISPR Genome Editing Market Forecast by Application (2019-2024)
    • 11.3 Biotechnology Companies Revenue Growth (2014-2019)
    • 11.4 Pharmaceutical Companies Revenue Growth (2014-2019)
    • 11.5 Others Revenue Growth (2014-2019)

    12 Global CRISPR Genome Editing Market Size Forecast (2019-2024)

    • 12.1 Global CRISPR Genome Editing Market Size Forecast (2019-2024)
    • 12.2 Global CRISPR Genome Editing Market Forecast by Regions (2019-2024)
    • 12.3 North America CRISPR Genome Editing Revenue Market Forecast (2019-2024)
    • 12.4 Europe CRISPR Genome Editing Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific CRISPR Genome Editing Revenue Market Forecast (2019-2024)
    • 12.6 South America CRISPR Genome Editing Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa CRISPR Genome Editing Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      CRISPR Genome editing is a group of technologies that give scientists the ability to change CRISPR.

      Scope of the Report:
      The global CRISPR Genome Editing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
      The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
      North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of CRISPR Genome Editing.
      Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
      This report studies the CRISPR Genome Editing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the CRISPR Genome Editing market by product type and applications/end industries.

      Market Segment by Companies, this report covers
      Editas Medicine
      CRISPR Therapeutics
      Horizon Discovery
      Sigma-Aldrich
      Genscript
      Sangamo Biosciences
      Lonza Group
      Integrated DNA Technologies
      New England Biolabs
      Origene Technologies
      Transposagen Biopharmaceuticals
      Thermo Fisher Scientific
      Caribou Biosciences
      Precision Biosciences
      Cellectis
      Intellia Therapeutics

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Genetic Engineering
      Gene Library
      Human Stem Cells
      Others

      Market Segment by Applications, can be divided into
      Biotechnology Companies
      Pharmaceutical Companies
      Others

      Buy now